Cleo Diagnostics Ltd Stock: price and insider trades · Australia
1 insider bought €276k of shares over the last 90 days, the latest by Unknown, filed 24 Aug 2026.
Cleo Diagnostics Ltd: what insiders have been doing
Cleo Diagnostics Ltd is a listed company. Its insiders report their share dealings to ASX. Over the twelve months to 8 November 2026, 3 filings were filed, from 2 insiders.
The flow runs one way only: 2 insiders bought (3 purchases totalling €276k) and nobody sold on the market. The totals exclude 2 filings filed without an amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The buyers include 2 senior executives. Lucinda Joan Frawley filed the largest purchase, €276k, on 24 August 2026.
The clock since the last published purchase (24 August 2026) now reads 76 days. Most trades are made public on the day they happen. This delay matters because a trade only becomes useful information once it is public.
With 3 filings in twelve months, the company is in line with the median of 3 filings across the 2,535 companies we follow on the same exchange. Over the whole record (from 2026), the tally stands at 3 purchases and no sales.
Source: insider filings from ASX. Past trades are no guide to future returns.
Who traded when
BuySaleSince the insiders bought
- Unknown-18.1%Entry A$0.36 · Close at T+30 A$0.29
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Financial data
as of FY 2026FY ended June 2026 · cache
- ▲Executives450,000 AUD0ASX
- ▲Executives0ASX
- ▲Executives0ASX
3 of 3 declarations
About Cleo Diagnostics Ltd
Cleo Diagnostics Ltd is a company listed on the XASX, specializing in the development of medical diagnostic solutions. It focuses on innovation in diagnostic testing to enhance healthcare.
